Page 24 - Sanket Koul

USTR flags hurdles for US med device exports to India before tariff move

Medtech manufacturers' groups expect negotiations may lead to fairer outcomes for both sides

USTR flags barriers for med device export to India ahead of Apr 2 deadline

Move comes even as domestic medtech manufacturers lobby asked GOI to work towards a fair deal

Over 600 private hospitals have opted out of Ayushman Bharat since 2018

Private players say lower rates, delayed dues hampering participation in the scheme

Spurious batch of Telma H flagged, 103 other drugs fail CDSCO tests

Telma H is manufactured by Glenmark Pharmaceuticals and is prescribed for controlling high blood pressure, particularly in individuals prone to water retention or heart failure

Cardiac stents to cost 2% more as regulator allows prices to be raised

National Pharmaceutical Pricing Authority allows manufacturers to make adjustment for inflation

Parl panel flags concerns over CBSE's dual board exam plan for Class 10

In its draft policy released last month, the CBSE had proposed conducting Class 10 board exams twice in an academic year from 2026

NPPA revises ceiling prices for over 900 drug formulations from April 1

With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government

Centre asks states to activate heat action plans, boost preparedness

The weatherman has also warned of "double heatwave" days in northwest India this summer season

Proposed circle rate hike to make property costlier in Noida, Jewar

Experts believe potential rise may enhance investor confidence in long run

NPPA to allow 1.74% hike in MRP of scheduled drugs in line with WPI rise

With this, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government in this regard

India may soon train select countries on best drug regulatory practices

The project will be an extension of the CDSCO and NIHFW's ongoing training programmes with drug inspectors from the central and state drug authorities

CDSCO asks MSME pharma firms to apply online for Schedule M extension

This comes after the health ministry had on February 11 formally extended the deadline for implementing the revised Schedule M by one year for pharma companies with an annual turnover below Rs 250 cr

Centre to expand its TB elimination campaign all over India: JP Nadda

This comes after the government's 100-day intensified TB screening campaign concluded on March 24, which is also World TB Day

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

The company currently operates more than 200 centres across India, both under public-private partnerships (PPP) and company-owned standalone clinics, serving over 20,000 patients annually

Real estate major DLF eyes Rs 74k cr in sales from new housing projects

Realty major targeting luxury housing market with products totalling 26 million square feet in pipeline

Housing supply down 34%, sales drop 23% in top 9 cities in Q1CY25: Report

Supply drops below 100,000 units for the third straight quarter

Mumbai temperatures hit five-year high; heat-related ailments rise 10-20%

Delhi, Kolkata expect surge in heat-related emergencies

Booster shot: Mounjaro may emerge as a sweet pill for Eli Lilly in India

Analysts say the diabetes and obesity drug can be a Rs 500 crore opportunity for the firm

Signature Global acquires 8.39 acre land in Gurugram for Rs 282 crore

The company said that the overall developable potential of the acquired land would be approximately 2 million square feet, with a total revenue of around Rs 3,200 crore

Trump Organisation to foray into Indian commercial real estate sector

"Estimated to be finished by 2029, the 1.6 million square feet centre is expected to generate sales exceeding Rs 2,500 crore," Kalpesh Mehta, founder of Tribeca developers told Business Standard